Tower Research Capital LLC (TRC) - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,770
-87.0%
939
-71.3%
0.00%
-100.0%
Q2 2023$82,840
+108900.0%
3,273
+38.0%
0.00%
+50.0%
Q1 2023$76
+33.3%
2,372
-23.1%
0.00%0.0%
Q4 2022$57
-100.0%
3,083
-40.9%
0.00%0.0%
Q3 2022$141,000
+200.0%
5,214
+54.1%
0.00%
+100.0%
Q2 2022$47,000
+147.4%
3,383
+252.4%
0.00%
Q1 2022$19,000
-20.8%
960
-33.7%
0.00%
Q4 2021$24,000
-64.7%
1,449
-40.5%
0.00%
-100.0%
Q3 2021$68,000
-79.3%
2,436
-78.1%
0.00%
-77.8%
Q2 2021$329,000
+75.9%
11,107
+66.3%
0.01%
+200.0%
Q1 2021$187,000
+45.0%
6,677
+47.0%
0.00%
-25.0%
Q4 2020$129,000
-60.4%
4,541
-65.0%
0.00%0.0%
Q3 2020$326,000
+105.0%
12,956
+98.6%
0.00%
-42.9%
Q2 2020$159,000
+231.2%
6,524
+119.7%
0.01%
+75.0%
Q4 2019$48,000
+200.0%
2,970
+147.5%
0.00%
+300.0%
Q3 2019$16,000
+128.6%
1,200
+387.8%
0.00%
Q2 2018$7,000
+250.0%
246
+434.8%
0.00%
Q4 2017$2,000
-97.7%
46
-98.5%
0.00%
-100.0%
Q3 2017$87,000
+443.8%
3,150
+425.0%
0.01%
+250.0%
Q2 2017$16,000
+100.0%
600
+20.0%
0.00%
+100.0%
Q3 2016$8,000
+300.0%
500
+161.8%
0.00%
Q2 2016$2,000
-86.7%
191
-77.2%
0.00%
-100.0%
Q1 2016$15,000
+36.4%
838
+151.7%
0.00%
+100.0%
Q2 2015$11,000
-77.1%
333
-85.6%
0.00%
-83.3%
Q1 2015$48,000
+128.6%
2,310
+86.1%
0.01%
+200.0%
Q4 2014$21,000
-52.3%
1,241
-11.4%
0.00%
-66.7%
Q1 2014$44,0001,4000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders